Travel and migration associated infectious diseases morbidity in Europe, 2008

<p>Abstract</p> <p>Background</p> <p>Europeans represent the majority of international travellers and clinicians encountering returned patients have an essential role in recognizing, and communicating travel-associated public health risks.</p> <p>Methods<...

Full description

Bibliographic Details
Main Authors: Lopez-Velez Rogelio, Weld Leisa, Gkrania-Klotsas Effrossyni, Castelli Francesco, Jensenius Mogens, Caumes Eric, Burchard Gerd-Dieter, Schlagenhauf Patricia, Gautret Philippe, Field Vanessa, de Vries Peter, von Sonnenburg Frank, Loutan Louis, Parola Philippe
Format: Article
Language:English
Published: BMC 2010-11-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/10/330
id doaj-fd1bcdc7dd894a769007b397b04db8bb
record_format Article
spelling doaj-fd1bcdc7dd894a769007b397b04db8bb2020-11-25T03:49:34ZengBMCBMC Infectious Diseases1471-23342010-11-0110133010.1186/1471-2334-10-330Travel and migration associated infectious diseases morbidity in Europe, 2008Lopez-Velez RogelioWeld LeisaGkrania-Klotsas EffrossyniCastelli FrancescoJensenius MogensCaumes EricBurchard Gerd-DieterSchlagenhauf PatriciaGautret PhilippeField Vanessade Vries Petervon Sonnenburg FrankLoutan LouisParola Philippe<p>Abstract</p> <p>Background</p> <p>Europeans represent the majority of international travellers and clinicians encountering returned patients have an essential role in recognizing, and communicating travel-associated public health risks.</p> <p>Methods</p> <p>To investigate the morbidity of travel associated infectious diseases in European travellers, we analysed diagnoses with demographic, clinical and travel-related predictors of disease, in 6957 ill returned travellers who presented in 2008 to EuroTravNet centres with a presumed travel associated condition.</p> <p>Results</p> <p>Gastro-intestinal (GI) diseases accounted for 33% of illnesses, followed by febrile systemic illnesses (20%), dermatological conditions (12%) and respiratory illnesses (8%). There were 3 deaths recorded; a sepsis caused by <it>Escherichia coli </it>pyelonephritis, a dengue shock syndrome and a <it>Plasmodium falciparum </it>malaria.</p> <p>GI conditions included bacterial acute diarrhea (6.9%), as well as giardiasis and amebasis (2.3%). Among febrile systemic illnesses with identified pathogens, malaria (5.4%) accounted for most cases followed by dengue (1.9%) and others including chikungunya, rickettsial diseases, leptospirosis, brucellosis, Epstein Barr virus infections, tick-borne encephalitis (TBE) and viral hepatitis. Dermatological conditions were dominated by bacterial infections, arthropod bites, cutaneous larva migrans and animal bites requiring rabies post-exposure prophylaxis and also leishmaniasis, myasis, tungiasis and one case of leprosy. Respiratory illness included 112 cases of tuberculosis including cases of multi-drug resistant or extensively drug resistant tuberculosis, 104 cases of influenza like illness, and 5 cases of Legionnaires disease. Sexually transmitted infections (STI) accounted for 0.6% of total diagnoses and included HIV infection and syphilis. A total of 165 cases of potentially vaccine preventable diseases were reported. Purpose of travel and destination specific risk factors was identified for several diagnoses such as Chagas disease in immigrant travellers from South America and <it>P. falciparum </it>malaria in immigrants from sub-Saharan Africa. Travel within Europe was also associated with health risks with distinctive profiles for Eastern and Western Europe.</p> <p>Conclusions</p> <p>In 2008, a broad spectrum of travel associated diseases were diagnosed at EuroTravNet core sites. Diagnoses varied according to regions visited by ill travellers. The spectrum of travel associated morbidity also shows that there is a need to dispel the misconception that travel, close to home, in Europe, is without significant health risk.</p> http://www.biomedcentral.com/1471-2334/10/330
collection DOAJ
language English
format Article
sources DOAJ
author Lopez-Velez Rogelio
Weld Leisa
Gkrania-Klotsas Effrossyni
Castelli Francesco
Jensenius Mogens
Caumes Eric
Burchard Gerd-Dieter
Schlagenhauf Patricia
Gautret Philippe
Field Vanessa
de Vries Peter
von Sonnenburg Frank
Loutan Louis
Parola Philippe
spellingShingle Lopez-Velez Rogelio
Weld Leisa
Gkrania-Klotsas Effrossyni
Castelli Francesco
Jensenius Mogens
Caumes Eric
Burchard Gerd-Dieter
Schlagenhauf Patricia
Gautret Philippe
Field Vanessa
de Vries Peter
von Sonnenburg Frank
Loutan Louis
Parola Philippe
Travel and migration associated infectious diseases morbidity in Europe, 2008
BMC Infectious Diseases
author_facet Lopez-Velez Rogelio
Weld Leisa
Gkrania-Klotsas Effrossyni
Castelli Francesco
Jensenius Mogens
Caumes Eric
Burchard Gerd-Dieter
Schlagenhauf Patricia
Gautret Philippe
Field Vanessa
de Vries Peter
von Sonnenburg Frank
Loutan Louis
Parola Philippe
author_sort Lopez-Velez Rogelio
title Travel and migration associated infectious diseases morbidity in Europe, 2008
title_short Travel and migration associated infectious diseases morbidity in Europe, 2008
title_full Travel and migration associated infectious diseases morbidity in Europe, 2008
title_fullStr Travel and migration associated infectious diseases morbidity in Europe, 2008
title_full_unstemmed Travel and migration associated infectious diseases morbidity in Europe, 2008
title_sort travel and migration associated infectious diseases morbidity in europe, 2008
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2010-11-01
description <p>Abstract</p> <p>Background</p> <p>Europeans represent the majority of international travellers and clinicians encountering returned patients have an essential role in recognizing, and communicating travel-associated public health risks.</p> <p>Methods</p> <p>To investigate the morbidity of travel associated infectious diseases in European travellers, we analysed diagnoses with demographic, clinical and travel-related predictors of disease, in 6957 ill returned travellers who presented in 2008 to EuroTravNet centres with a presumed travel associated condition.</p> <p>Results</p> <p>Gastro-intestinal (GI) diseases accounted for 33% of illnesses, followed by febrile systemic illnesses (20%), dermatological conditions (12%) and respiratory illnesses (8%). There were 3 deaths recorded; a sepsis caused by <it>Escherichia coli </it>pyelonephritis, a dengue shock syndrome and a <it>Plasmodium falciparum </it>malaria.</p> <p>GI conditions included bacterial acute diarrhea (6.9%), as well as giardiasis and amebasis (2.3%). Among febrile systemic illnesses with identified pathogens, malaria (5.4%) accounted for most cases followed by dengue (1.9%) and others including chikungunya, rickettsial diseases, leptospirosis, brucellosis, Epstein Barr virus infections, tick-borne encephalitis (TBE) and viral hepatitis. Dermatological conditions were dominated by bacterial infections, arthropod bites, cutaneous larva migrans and animal bites requiring rabies post-exposure prophylaxis and also leishmaniasis, myasis, tungiasis and one case of leprosy. Respiratory illness included 112 cases of tuberculosis including cases of multi-drug resistant or extensively drug resistant tuberculosis, 104 cases of influenza like illness, and 5 cases of Legionnaires disease. Sexually transmitted infections (STI) accounted for 0.6% of total diagnoses and included HIV infection and syphilis. A total of 165 cases of potentially vaccine preventable diseases were reported. Purpose of travel and destination specific risk factors was identified for several diagnoses such as Chagas disease in immigrant travellers from South America and <it>P. falciparum </it>malaria in immigrants from sub-Saharan Africa. Travel within Europe was also associated with health risks with distinctive profiles for Eastern and Western Europe.</p> <p>Conclusions</p> <p>In 2008, a broad spectrum of travel associated diseases were diagnosed at EuroTravNet core sites. Diagnoses varied according to regions visited by ill travellers. The spectrum of travel associated morbidity also shows that there is a need to dispel the misconception that travel, close to home, in Europe, is without significant health risk.</p>
url http://www.biomedcentral.com/1471-2334/10/330
work_keys_str_mv AT lopezvelezrogelio travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT weldleisa travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT gkraniaklotsaseffrossyni travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT castellifrancesco travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT jenseniusmogens travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT caumeseric travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT burchardgerddieter travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT schlagenhaufpatricia travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT gautretphilippe travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT fieldvanessa travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT devriespeter travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT vonsonnenburgfrank travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT loutanlouis travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
AT parolaphilippe travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008
_version_ 1724494779985690624